InvestorsHub Logo
Followers 183
Posts 30024
Boards Moderated 3
Alias Born 07/09/2003

Re: None

Tuesday, 10/29/2019 7:04:11 PM

Tuesday, October 29, 2019 7:04:11 PM

Post# of 75
Just to be fair this is something to consider at this time of near triple of lows before the news:



DewDiligence Member Level Tuesday, 10/29/19 06:16:22 PM
Re: swampboots post# 226558 0
Post # of 226566



ISEE isn’t getting much respect because it’s the renamed OPHT, whose Fovista failed horrifically in wet AMD (#msg-148256773, #msg-127913009, #msg-127173982, #msg-133812911).

As for Zimura... it, too, was a wet-AMD drug that’s been repurposed for dry AMD (https://www.mdmag.com/medical-news/zimura-lucentis-combo-safe-but-company-decides-not-to-move-forward ); it might work, of course, but I wouldn’t bank on it.


Respond | View Replies (1)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.